PureTech Health Future Growth
Future criteria checks 0/6
PureTech Health is forecast to grow earnings and revenue by 4.6% and 57.5% per annum respectively. EPS is expected to decline by 47.3% per annum. Return on equity is forecast to be -98.4% in 3 years.
Key information
4.6%
Earnings growth rate
-47.3%
EPS growth rate
Biotechs earnings growth | 30.2% |
Revenue growth rate | 57.5% |
Future return on equity | -98.4% |
Analyst coverage | Low |
Last updated | 05 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 24 | -253 | N/A | N/A | 2 |
12/31/2025 | 37 | -191 | -198 | -191 | 2 |
12/31/2024 | N/A | -213 | -196 | -189 | 1 |
12/31/2023 | 3 | -66 | -106 | -106 | N/A |
9/30/2023 | 8 | -56 | -132 | -131 | N/A |
6/30/2023 | 12 | -47 | -157 | -157 | N/A |
3/31/2023 | 14 | -49 | -169 | -168 | N/A |
12/31/2022 | 16 | -50 | -181 | -179 | N/A |
9/30/2022 | 17 | -32 | -183 | -179 | N/A |
6/30/2022 | 19 | -14 | -185 | -180 | N/A |
3/31/2022 | 18 | -37 | -174 | -169 | N/A |
12/31/2021 | 17 | -61 | -164 | -158 | N/A |
9/30/2021 | 14 | -127 | -156 | -150 | N/A |
6/30/2021 | 11 | -193 | -147 | -141 | N/A |
3/31/2021 | 11 | -94 | -142 | -136 | N/A |
12/31/2020 | 12 | 6 | -137 | -132 | N/A |
9/30/2020 | 12 | 239 | -121 | -115 | N/A |
6/30/2020 | 12 | 472 | -104 | -99 | N/A |
3/31/2020 | 11 | 446 | -107 | -99 | N/A |
12/31/2019 | 10 | 421 | -111 | -98 | N/A |
9/30/2019 | 15 | 229 | -103 | -91 | N/A |
6/30/2019 | 20 | 37 | -96 | -84 | N/A |
3/31/2019 | 20 | -3 | -87 | -78 | N/A |
12/31/2018 | 21 | -44 | -77 | -73 | N/A |
9/30/2018 | 14 | 9 | -84 | -81 | N/A |
6/30/2018 | 7 | 61 | -91 | -88 | N/A |
3/31/2018 | 5 | 44 | -91 | -88 | N/A |
12/31/2017 | 3 | 26 | -91 | -89 | N/A |
9/30/2017 | 4 | -17 | N/A | -81 | N/A |
6/30/2017 | 5 | -61 | N/A | -74 | N/A |
3/31/2017 | 5 | -55 | N/A | -66 | N/A |
12/31/2016 | 4 | -49 | N/A | -58 | N/A |
9/30/2016 | 3 | -54 | N/A | -57 | N/A |
6/30/2016 | 1 | -59 | N/A | -55 | N/A |
3/31/2016 | 6 | -49 | N/A | -42 | N/A |
12/31/2015 | 12 | -39 | N/A | -29 | N/A |
9/30/2015 | 12 | -37 | N/A | -19 | N/A |
6/30/2015 | 12 | -35 | N/A | -9 | N/A |
3/31/2015 | 7 | -38 | N/A | -10 | N/A |
12/31/2014 | 2 | -42 | N/A | -11 | N/A |
12/31/2013 | 9 | -5 | N/A | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0VQ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0VQ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0VQ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0VQ is forecast to have no revenue next year.
High Growth Revenue: 0VQ is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0VQ is forecast to be unprofitable in 3 years.